The Role of Platelet-Rich Plasma (PRP) in Enhancing IVF Success in Women With Ovarian Insufficiency: A Cohort Study

Ovarian insufficiency is a significant cause of infertility in women, with limited effective treatment options. Platelet-Rich Plasma (PRP), rich in concentrated growth factors, has shown regenerative potential in various medical fields. However, its efficacy as an adjunct in infertility treatment,...

Full description

Saved in:
Bibliographic Details
Main Authors: Zahra Mohammad Alipour, Farahnazsadat Ahmadi, Sina Mohajernoei, Roghaye Gharaei, Nazanin Hojjati, Elham Shirali, Firouzeh Akbari Asbagh
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2025-01-01
Series:Acta Medica Iranica
Subjects:
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/11420
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823863946356981760
author Zahra Mohammad Alipour
Farahnazsadat Ahmadi
Sina Mohajernoei
Roghaye Gharaei
Nazanin Hojjati
Elham Shirali
Firouzeh Akbari Asbagh
author_facet Zahra Mohammad Alipour
Farahnazsadat Ahmadi
Sina Mohajernoei
Roghaye Gharaei
Nazanin Hojjati
Elham Shirali
Firouzeh Akbari Asbagh
author_sort Zahra Mohammad Alipour
collection DOAJ
description Ovarian insufficiency is a significant cause of infertility in women, with limited effective treatment options. Platelet-Rich Plasma (PRP), rich in concentrated growth factors, has shown regenerative potential in various medical fields. However, its efficacy as an adjunct in infertility treatment, particularly in women with ovarian insufficiency, remains unclear. This study investigates whether PRP administration improves the success of IVF cycles in this specific population. This cohort study followed women with ovarian insufficiency undergoing IVF at a fertility center. Participants were divided into two groups: the intervention group, which received PRP alongside the standard IVF protocol, and the control group, which received only the standard protocol. Data collected included patient demographics, hormonal levels, number and quality of retrieved oocytes, fertilization rates, embryo quality, and pregnancy outcomes. The primary outcome was IVF success, defined by clinical pregnancy rates. Secondary outcomes included hormonal changes, oocyte quality, and embryo development. Statistical analysis utilized descriptive statistics, chi-square tests, and t-tests to compare outcomes between groups. PRP administration led to significant reductions in FSH levels (P<0.001) and marked increases in AMH levels and antral follicle count (AFC) (P=0.001 and P<0.001, respectively). The number of oocytes, mature MII oocytes, and Grade A embryos also improved significantly (P ranging from 0.004 to 0.017). Although the increase in Grade B embryos was not statistically significant, it was higher post-PRP. Chemical pregnancies occurred in 25% of participants, with 20.83% resulting in clinical pregnancies, including 2.1% spontaneous pregnancies. PRP significantly enhanced ovarian reserve markers (FSH, AMH, AFC), oocyte quality, and embryo development, translating into improved fertility outcomes. The findings suggest that with longer follow-up and larger sample sizes, PRP could be validated as a promising adjunctive therapy for women with ovarian insufficiency undergoing IVF. These results align with prior research and highlight PRP’s potential to advance reproductive outcomes in this challenging patient population.  
format Article
id doaj-art-c198e745ddaa49ae91b3e4c835bd6c45
institution Kabale University
issn 0044-6025
1735-9694
language English
publishDate 2025-01-01
publisher Tehran University of Medical Sciences
record_format Article
series Acta Medica Iranica
spelling doaj-art-c198e745ddaa49ae91b3e4c835bd6c452025-02-09T08:50:52ZengTehran University of Medical SciencesActa Medica Iranica0044-60251735-96942025-01-0162510.18502/acta.v62i5.17774The Role of Platelet-Rich Plasma (PRP) in Enhancing IVF Success in Women With Ovarian Insufficiency: A Cohort StudyZahra Mohammad Alipour0Farahnazsadat Ahmadi1Sina Mohajernoei2Roghaye Gharaei3Nazanin Hojjati4Elham Shirali5Firouzeh Akbari Asbagh6Department of Obstetrics and Gynecology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran .Department of Obstetrics and Gynecology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran .Department of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.Department of Obstetrics and Gynecology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.Department of Obstetrics and Gynecology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.Department of Gynecologic Oncology, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran.Department of Obstetrics and Gynecology, School of Medicine, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran Ovarian insufficiency is a significant cause of infertility in women, with limited effective treatment options. Platelet-Rich Plasma (PRP), rich in concentrated growth factors, has shown regenerative potential in various medical fields. However, its efficacy as an adjunct in infertility treatment, particularly in women with ovarian insufficiency, remains unclear. This study investigates whether PRP administration improves the success of IVF cycles in this specific population. This cohort study followed women with ovarian insufficiency undergoing IVF at a fertility center. Participants were divided into two groups: the intervention group, which received PRP alongside the standard IVF protocol, and the control group, which received only the standard protocol. Data collected included patient demographics, hormonal levels, number and quality of retrieved oocytes, fertilization rates, embryo quality, and pregnancy outcomes. The primary outcome was IVF success, defined by clinical pregnancy rates. Secondary outcomes included hormonal changes, oocyte quality, and embryo development. Statistical analysis utilized descriptive statistics, chi-square tests, and t-tests to compare outcomes between groups. PRP administration led to significant reductions in FSH levels (P<0.001) and marked increases in AMH levels and antral follicle count (AFC) (P=0.001 and P<0.001, respectively). The number of oocytes, mature MII oocytes, and Grade A embryos also improved significantly (P ranging from 0.004 to 0.017). Although the increase in Grade B embryos was not statistically significant, it was higher post-PRP. Chemical pregnancies occurred in 25% of participants, with 20.83% resulting in clinical pregnancies, including 2.1% spontaneous pregnancies. PRP significantly enhanced ovarian reserve markers (FSH, AMH, AFC), oocyte quality, and embryo development, translating into improved fertility outcomes. The findings suggest that with longer follow-up and larger sample sizes, PRP could be validated as a promising adjunctive therapy for women with ovarian insufficiency undergoing IVF. These results align with prior research and highlight PRP’s potential to advance reproductive outcomes in this challenging patient population.   https://acta.tums.ac.ir/index.php/acta/article/view/11420InfertilityOvarian insufficiencyPlatelet-rich plasma (PRP)In vitro fertilization (IVF)Oocyte qualityEmbryo quality
spellingShingle Zahra Mohammad Alipour
Farahnazsadat Ahmadi
Sina Mohajernoei
Roghaye Gharaei
Nazanin Hojjati
Elham Shirali
Firouzeh Akbari Asbagh
The Role of Platelet-Rich Plasma (PRP) in Enhancing IVF Success in Women With Ovarian Insufficiency: A Cohort Study
Acta Medica Iranica
Infertility
Ovarian insufficiency
Platelet-rich plasma (PRP)
In vitro fertilization (IVF)
Oocyte quality
Embryo quality
title The Role of Platelet-Rich Plasma (PRP) in Enhancing IVF Success in Women With Ovarian Insufficiency: A Cohort Study
title_full The Role of Platelet-Rich Plasma (PRP) in Enhancing IVF Success in Women With Ovarian Insufficiency: A Cohort Study
title_fullStr The Role of Platelet-Rich Plasma (PRP) in Enhancing IVF Success in Women With Ovarian Insufficiency: A Cohort Study
title_full_unstemmed The Role of Platelet-Rich Plasma (PRP) in Enhancing IVF Success in Women With Ovarian Insufficiency: A Cohort Study
title_short The Role of Platelet-Rich Plasma (PRP) in Enhancing IVF Success in Women With Ovarian Insufficiency: A Cohort Study
title_sort role of platelet rich plasma prp in enhancing ivf success in women with ovarian insufficiency a cohort study
topic Infertility
Ovarian insufficiency
Platelet-rich plasma (PRP)
In vitro fertilization (IVF)
Oocyte quality
Embryo quality
url https://acta.tums.ac.ir/index.php/acta/article/view/11420
work_keys_str_mv AT zahramohammadalipour theroleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT farahnazsadatahmadi theroleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT sinamohajernoei theroleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT roghayegharaei theroleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT nazaninhojjati theroleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT elhamshirali theroleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT firouzehakbariasbagh theroleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT zahramohammadalipour roleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT farahnazsadatahmadi roleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT sinamohajernoei roleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT roghayegharaei roleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT nazaninhojjati roleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT elhamshirali roleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy
AT firouzehakbariasbagh roleofplateletrichplasmaprpinenhancingivfsuccessinwomenwithovarianinsufficiencyacohortstudy